Elevated fecal calprotectin values appear more common following esophagogastric than colon surgery

Read full text Summarise with VIRAT
Authors: Wolfgang Johann Schnedl, Simon Michaelis, Rudolf Schrittwieser, Dietmar Enko, Sandra Johanna Holasek
Cited by: 0
References: 25

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Fecal calprotectin (FCAL) is commonly used to exclude inflammatory bowel disease in patients with symptoms of the irritable bowel syndrome spectrum. This retrospective case–control study evaluated FCAL levels in 81 postoperative patients to assess the impact of different gastrointestinal surgeries. Thirty-one patients had undergone esophago-gastric surgery (fundoplication or Roux-en-Y gastric bypass), and 50 had undergone colon surgery with hemicolectomy. Elevated FCAL levels (>50 μg/g) were observed in 56.7% of patients after esophago-gastric surgery compared with 24% of patients after hemicolectomy. Median FCAL levels were 96 μg/g and 99 μg/g, respectively. Statistically significant differences in FCAL levels were found between patients who underwent left-sided hemicolectomy and those who underwent Roux-en-Y bypass (P < .001), as well as right-sided hemicolectomy (P = .042). Overall, elevated FCAL levels were more than twice as common following esophago-gastric surgery, suggesting surgery-specific patterns of postoperative intestinal inflammation.

Fields of Study & Subjects

Inflammatory Bowel Disease Gastrointestinal motility and disorders Enhanced Recovery After Surgery

Publication details

Journal / source
Journal of Surgical Case Reports
Volume
2026
Issue
3
Pages
rjag188–rjag188
Publication date
1 March 2026
Language
EN